Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Malaria journal - 8 May 2024

Thu Aung Myint, Phyo Aung Pyae, Pateekhum Chanapat, Rae Jade D, Landier Jordi, Parker Daniel M, Delmas Gilles, Watthanaworawit Wanitda, McLean Alistair R D, Arya Ann, Reyes Ann, Li Xue, Miotto Olivo, Soe Kyaw, Ashley Elizabeth A, Dondorp Arjen, White Nicholas J, Day Nicholas P, Anderson Tim J C, Imwong Mallika, Nosten Francois, Smithuis Frank

Abstract excerpt

BACKGROUND: Artemisinin resistance in Plasmodium falciparum threatens global malaria elimination efforts. To contain and then eliminate artemisinin resistance in Eastern Myanmar a network of community-based malaria posts was instituted and targeted mass drug administration (MDA) with dihydroartemisinin-piperaquine (three rounds at monthly intervals) was conducted. The prevalence of artemisinin resistance during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Artemisinins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Malaria, Falciparum

Share to Myanmar

Share to Piperazines

Share to Plasmodium falciparum

Share to Quinolines

Source

Open in PubMed Open full text

Identifiers

PMID: 38720269
DOI: 10.1186/s12936-024-04955-6
PMCID: PMC11078751

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.PMID 38720269Read ↗

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern MyanmarSemantic proximity Read ↗

Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.Semantic proximity Read ↗

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.Semantic proximity Read ↗

Malaria parasite population genomics during an elimination program in Eastern MyanmarSemantic proximity Read ↗

Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Semantic proximity Read ↗

Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Retain High Efficacy for Treatment of Uncomplicated Plasmodium falciparum Malaria in Myanmar.Semantic proximity Read ↗

Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar.Semantic proximity Read ↗

Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar.Semantic proximity Read ↗

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.Semantic proximity Read ↗

Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.Semantic proximity Read ↗

Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)Semantic proximity Read ↗

Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.